{"id":"https://openalex.org/W2010490262","doi":"https://doi.org/10.1089/ars.2009.2445","title":"Mitochondria Targeted Peptides Protect Against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Neurotoxicity","display_name":"Mitochondria Targeted Peptides Protect Against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Neurotoxicity","publication_year":2009,"publication_date":"2009-02-09","ids":{"openalex":"https://openalex.org/W2010490262","doi":"https://doi.org/10.1089/ars.2009.2445","mag":"2010490262","pmid":"https://pubmed.ncbi.nlm.nih.gov/19203217","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2819801"},"language":"en","primary_location":{"id":"doi:10.1089/ars.2009.2445","doi":"https://doi.org/10.1089/ars.2009.2445","is_oa":false,"landing_page_url":"https://doi.org/10.1089/ars.2009.2445","pdf_url":null,"source":{"id":"https://openalex.org/S88052261","display_name":"Antioxidants and Redox Signaling","issn_l":"1523-0864","issn":["1523-0864","1557-7716"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antioxidants &amp; Redox Signaling","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2010490262"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2819801/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100554965","display_name":"Lichuan Yang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1340179700","display_name":"NewYork\u2013Presbyterian Hospital","ror":"https://ror.org/03gzbrs57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1340179700"]},{"id":"https://openalex.org/I205783295","display_name":"Cornell University","ror":"https://ror.org/05bnh6r87","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lichuan Yang","raw_affiliation_strings":["Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York-Presbyterian Hospital, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York-Presbyterian Hospital, New York, New York","institution_ids":["https://openalex.org/I1340179700","https://openalex.org/I205783295"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111487377","display_name":"Kesheng Zhao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1340179700","display_name":"NewYork\u2013Presbyterian Hospital","ror":"https://ror.org/03gzbrs57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1340179700"]},{"id":"https://openalex.org/I205783295","display_name":"Cornell University","ror":"https://ror.org/05bnh6r87","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kesheng Zhao","raw_affiliation_strings":["Department of Pharmacology, Weill Medical College of Cornell University, New York-Presbyterian Hospital, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Weill Medical College of Cornell University, New York-Presbyterian Hospital, New York, New York","institution_ids":["https://openalex.org/I1340179700","https://openalex.org/I205783295"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081903506","display_name":"Noel Ylagan Calingasan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1340179700","display_name":"NewYork\u2013Presbyterian Hospital","ror":"https://ror.org/03gzbrs57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1340179700"]},{"id":"https://openalex.org/I205783295","display_name":"Cornell University","ror":"https://ror.org/05bnh6r87","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Noel Y. Calingasan","raw_affiliation_strings":["Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York-Presbyterian Hospital, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York-Presbyterian Hospital, New York, New York","institution_ids":["https://openalex.org/I1340179700","https://openalex.org/I205783295"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072241732","display_name":"Guoxiong Luo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1340179700","display_name":"NewYork\u2013Presbyterian Hospital","ror":"https://ror.org/03gzbrs57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1340179700"]},{"id":"https://openalex.org/I205783295","display_name":"Cornell University","ror":"https://ror.org/05bnh6r87","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guoxiong Luo","raw_affiliation_strings":["Department of Pharmacology, Weill Medical College of Cornell University, New York-Presbyterian Hospital, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Weill Medical College of Cornell University, New York-Presbyterian Hospital, New York, New York","institution_ids":["https://openalex.org/I1340179700","https://openalex.org/I205783295"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087249159","display_name":"Hazel H. Szeto","orcid":"https://orcid.org/0000-0003-4021-5076","observed_orcids":["https://orcid.org/0000-0003-4021-5076"]},"institutions":[{"id":"https://openalex.org/I1340179700","display_name":"NewYork\u2013Presbyterian Hospital","ror":"https://ror.org/03gzbrs57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1340179700"]},{"id":"https://openalex.org/I205783295","display_name":"Cornell University","ror":"https://ror.org/05bnh6r87","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hazel H. Szeto","raw_affiliation_strings":["Department of Pharmacology, Weill Medical College of Cornell University, New York-Presbyterian Hospital, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Weill Medical College of Cornell University, New York-Presbyterian Hospital, New York, New York","institution_ids":["https://openalex.org/I1340179700","https://openalex.org/I205783295"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108432384","display_name":"M. Flint Beal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1340179700","display_name":"NewYork\u2013Presbyterian Hospital","ror":"https://ror.org/03gzbrs57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1340179700"]},{"id":"https://openalex.org/I205783295","display_name":"Cornell University","ror":"https://ror.org/05bnh6r87","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"M. Flint Beal","raw_affiliation_strings":["Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York-Presbyterian Hospital, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York-Presbyterian Hospital, New York, New York","institution_ids":["https://openalex.org/I1340179700","https://openalex.org/I205783295"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5108432384"],"corresponding_institution_ids":["https://openalex.org/I1340179700","https://openalex.org/I205783295"],"apc_list":null,"apc_paid":null,"fwci":8.3207,"has_fulltext":false,"cited_by_count":170,"citation_normalized_percentile":{"value":0.98186667,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"11","issue":"9","first_page":"2095","last_page":"2104"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10301","display_name":"Mitochondrial Function and Pathology","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mitochondria-targeted-peptide","display_name":"mitochondria-targeted peptide","score":0.9800000190734863},{"id":"https://openalex.org/keywords/ss-31","display_name":"SS-31","score":0.9039999842643738},{"id":"https://openalex.org/keywords/mptp-neurotoxicity","display_name":"MPTP-induced neurotoxicity","score":0.9369999766349792},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.9869999885559082},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.8610000014305115},{"id":"https://openalex.org/keywords/mitochondrial-dysfunction","display_name":"mitochondrial dysfunction","score":0.7260000109672546},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.8149999976158142},{"id":"https://openalex.org/keywords/dopamine-depletion","display_name":"dopamine depletion","score":0.5569999814033508},{"id":"https://openalex.org/keywords/substantia-nigra-pars-compacta","display_name":"substantia nigra pars compacta","score":0.9340000152587891},{"id":"https://openalex.org/keywords/mpp","display_name":"MPP+","score":0.5839999914169312},{"id":"https://openalex.org/keywords/mitochondrial-swelling","display_name":"mitochondrial swelling","score":0.8379999995231628},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.4699999988079071},{"id":"https://openalex.org/keywords/oxygen-consumption","display_name":"oxygen consumption","score":0.5870000123977661},{"id":"https://openalex.org/keywords/atp-production","display_name":"ATP production","score":0.7919999957084656},{"id":"https://openalex.org/keywords/dopaminergic-neurons","display_name":"dopaminergic neurons","score":0.7039999961853027}],"concepts":[{"id":"https://openalex.org/C2778674702","wikidata":"https://www.wikidata.org/wiki/Q239816","display_name":"MPTP","level":4,"score":0.8888609409332275},{"id":"https://openalex.org/C2780938664","wikidata":"https://www.wikidata.org/wiki/Q753278","display_name":"Substantia nigra","level":4,"score":0.8310402631759644},{"id":"https://openalex.org/C2779491297","wikidata":"https://www.wikidata.org/wiki/Q3338704","display_name":"Neurotoxicity","level":3,"score":0.785818338394165},{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.7613945603370667},{"id":"https://openalex.org/C28859421","wikidata":"https://www.wikidata.org/wiki/Q39572","display_name":"Mitochondrion","level":2,"score":0.7066172361373901},{"id":"https://openalex.org/C2776773494","wikidata":"https://www.wikidata.org/wiki/Q3366041","display_name":"Pars compacta","level":5,"score":0.6737929582595825},{"id":"https://openalex.org/C159167319","wikidata":"https://www.wikidata.org/wiki/Q420766","display_name":"Tyrosine hydroxylase","level":3,"score":0.6124640703201294},{"id":"https://openalex.org/C2780358027","wikidata":"https://www.wikidata.org/wiki/Q407752","display_name":"Neurotoxin","level":2,"score":0.5993459224700928},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.5731427669525146},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.5615940093994141},{"id":"https://openalex.org/C48349386","wikidata":"https://www.wikidata.org/wiki/Q424361","display_name":"Reactive oxygen species","level":2,"score":0.5468390583992004},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5214504599571228},{"id":"https://openalex.org/C2776151105","wikidata":"https://www.wikidata.org/wiki/Q898814","display_name":"Oxidative stress","level":2,"score":0.48904117941856384},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.4259806275367737},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.42476779222488403},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.41891977190971375},{"id":"https://openalex.org/C2778175917","wikidata":"https://www.wikidata.org/wiki/Q17125553","display_name":"Mitochondrial ROS","level":3,"score":0.41408324241638184},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.37515994906425476},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.23345419764518738},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2314179241657257},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.20347312092781067},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.16683825850486755},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.06324928998947144}],"mesh":[{"descriptor_ui":"D000255","descriptor_name":"Adenosine Triphosphate","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003342","descriptor_name":"Corpus Striatum","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008930","descriptor_name":"Mitochondria, Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008930","descriptor_name":"Mitochondria, Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010101","descriptor_name":"Oxygen Consumption","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013378","descriptor_name":"Substantia Nigra","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D015632","descriptor_name":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020267","descriptor_name":"MPTP Poisoning","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1089/ars.2009.2445","doi":"https://doi.org/10.1089/ars.2009.2445","is_oa":false,"landing_page_url":"https://doi.org/10.1089/ars.2009.2445","pdf_url":null,"source":{"id":"https://openalex.org/S88052261","display_name":"Antioxidants and Redox Signaling","issn_l":"1523-0864","issn":["1523-0864","1557-7716"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antioxidants &amp; Redox Signaling","raw_type":"journal-article"},{"id":"pmid:19203217","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19203217","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antioxidants & redox signaling","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2819801","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2819801/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antioxid Redox Signal","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:2819801","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2819801/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antioxid Redox Signal","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3372205475","display_name":"Cell-Permeable Peptides for Mitochondrial Protection","funder_award_id":"R21NS048295","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"},{"id":"https://openalex.org/G8072001316","display_name":"SYSTEMICALLY-ACTIVE OPIOID PEPTIDE ANALOGS","funder_award_id":"P01DA008924","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320306078","display_name":"U.S. Department of Defense","ror":"https://ror.org/0447fe631"},{"id":"https://openalex.org/F4320306136","display_name":"Michael J. Fox Foundation for Parkinson's Research","ror":"https://ror.org/03arq3225"},{"id":"https://openalex.org/F4320306471","display_name":"Parkinson's Disease Foundation","ror":"https://ror.org/05mx85j86"},{"id":"https://openalex.org/F4320314997","display_name":"Strong","ror":"https://ror.org/041vyzr56"},{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"},{"id":"https://openalex.org/F4320337359","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":48,"referenced_works":["https://openalex.org/W1502303178","https://openalex.org/W1504584187","https://openalex.org/W1930159471","https://openalex.org/W1954166865","https://openalex.org/W1964879817","https://openalex.org/W1971632924","https://openalex.org/W1973205178","https://openalex.org/W1974800756","https://openalex.org/W1979469844","https://openalex.org/W1999378703","https://openalex.org/W2003139013","https://openalex.org/W2005718633","https://openalex.org/W2024994588","https://openalex.org/W2029651151","https://openalex.org/W2031228038","https://openalex.org/W2032478715","https://openalex.org/W2032515864","https://openalex.org/W2034049989","https://openalex.org/W2035609698","https://openalex.org/W2036154524","https://openalex.org/W2048654159","https://openalex.org/W2049195715","https://openalex.org/W2054415450","https://openalex.org/W2055456981","https://openalex.org/W2062833196","https://openalex.org/W2071249136","https://openalex.org/W2071274761","https://openalex.org/W2076009173","https://openalex.org/W2077260129","https://openalex.org/W2086129284","https://openalex.org/W2087528807","https://openalex.org/W2091187148","https://openalex.org/W2092718544","https://openalex.org/W2093932158","https://openalex.org/W2097281218","https://openalex.org/W2112777355","https://openalex.org/W2129248872","https://openalex.org/W2129755489","https://openalex.org/W2130753694","https://openalex.org/W2132110706","https://openalex.org/W2148726772","https://openalex.org/W2152165298","https://openalex.org/W2155395884","https://openalex.org/W2161546338","https://openalex.org/W2166196917","https://openalex.org/W2167924904","https://openalex.org/W2171873547","https://openalex.org/W2465342821"],"related_works":["https://openalex.org/W2050604139","https://openalex.org/W2082966118","https://openalex.org/W2091834895","https://openalex.org/W2270663127","https://openalex.org/W4378230614","https://openalex.org/W2092107930","https://openalex.org/W2069356567","https://openalex.org/W2226096027","https://openalex.org/W2070022218","https://openalex.org/W2089982008"],"abstract_inverted_index":{"A":[0,22],"large":[1],"body":[2],"of":[3,18,24,32,39,59,80,91,121,156,189],"evidence":[4,169],"suggests":[5],"that":[6,42,148,170],"mitochondrial":[7,46,163,177],"dysfunction":[8,178],"and":[9,48,63,82,126,151,159,162,179],"oxidative":[10,180],"damage":[11],"play":[12],"a":[13,37,183],"role":[14],"in":[15,29,71,85,96,108,132,138],"the":[16,57,187],"pathogenesis":[17],"Parkinson's":[19],"disease":[20],"(PD).":[21],"number":[23],"antioxidants":[25],"have":[26,35],"been":[27],"effective":[28],"animal":[30],"models":[31],"PD.":[33,190],"We":[34],"developed":[36],"family":[38],"mitochondria-targeted":[40],"peptides":[41],"can":[43],"protect":[44,66],"against":[45,67,78],"swelling":[47],"apoptosis":[49],"(SS":[50],"peptides).":[51],"In":[52],"this":[53],"study,":[54],"we":[55],"examined":[56],"ability":[58,107],"two":[60],"peptides,":[61,173],"SS-31":[62,73,125,150],"SS-20,":[64,101],"to":[65],"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine":[68],"(MPTP)":[69],"neurotoxicity":[70],"mice.":[72,123],"produced":[74],"dose-dependent":[75],"complete":[76],"protection":[77],"loss":[79,90],"dopamine":[81,140],"its":[83],"metabolites":[84],"striatum,":[86],"as":[87,89],"well":[88],"tyrosine":[92],"hydroxylase":[93],"immunoreactive":[94],"neurons":[95,120],"substantia":[97],"nigra":[98],"pars":[99],"compacta.":[100],"which":[102,174],"does":[103],"not":[104],"possess":[105],"intrinsic":[106],"scavenging":[109],"reactive":[110],"oxygen":[111,157],"species,":[112],"also":[113],"demonstrated":[114],"significant":[115],"neuroprotective":[116,172],"effects":[117],"on":[118],"dopaminergic":[119],"MPTP-treated":[122],"Both":[124],"SS-20":[127,152],"were":[128],"very":[129],"potent":[130],"(nM)":[131],"preventing":[133],"MPP+":[134],"(1-methyl-4-phenylpyridinium)-induced":[135],"cell":[136],"death":[137],"cultured":[139],"cells":[141],"(SN4741).":[142],"Studies":[143],"with":[144],"isolated":[145],"mitochondria":[146],"showed":[147],"both":[149,176],"prevented":[153],"MPP+-induced":[154],"inhibition":[155],"consumption":[158],"ATP":[160],"production,":[161],"swelling.":[164],"These":[165],"findings":[166],"provide":[167],"strong":[168],"these":[171],"target":[175],"damage,":[181],"are":[182],"promising":[184],"approach":[185],"for":[186],"treatment":[188]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":13},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":13},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":14},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}
